SSH - AKRON LLC — History
CCN 362027 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$31M
Latest Revenue (FY2022)
-0.7%
Revenue CAGR (3yr)
-3.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $32M | $38M | $31M | -17.0% | -0.7% |
| Operating Expenses | $27M | $32M | $32M | +1.5% | +8.5% |
| Operating Margin | 13.7% | 15.7% | -3.1% | -119.5% | +0.0% |
| Net Income | $4M | $6M | $-1M | -116.2% | +0.0% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 17,134 | 17,507 | 15,966 | -8.8% | -3.5% |
| Medicare Day % | 32% | 26% | 21% | -19.9% | -18.5% |
| Medicaid Day % | 7% | 2% | 11% | +337.3% | +20.5% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -1.4% ($32M → $31M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.7%
This Hospital
+7.6%
State Avg
Latest Margin
-3.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $31M | -11.5% |
| FY2024 (proj) | $31M | -19.9% |
| FY2025 (proj) | $30M | -28.3% |